elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q35057308-7C4A7514-06A4-4A71-9604-F93EE9E35B4C
Q35057308-7C4A7514-06A4-4A71-9604-F93EE9E35B4C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35057308-7C4A7514-06A4-4A71-9604-F93EE9E35B4C
Alectinib induces a durable (>15 months) complete response in an ALK-positive non-small cell lung cancer patient who progressed on crizotinib with diffuse leptomeningeal carcinomatosis.
P304
Q35057308-7C4A7514-06A4-4A71-9604-F93EE9E35B4C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35057308-7C4A7514-06A4-4A71-9604-F93EE9E35B4C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
bce5dc612662230df898e32596f48e3b65d2801e
P304
224-226
http://www.w3.org/2001/XMLSchema#string